The study at the University of Rochester used data from more than 1,300 male patients. It found those who were taking non-steroidal anti-inflammatory like aspirin showed a 10 percent drop in their blood levels of prostate-specific antigens versus patients not taking it.
Researchers say their findings are consistent with previous studies showing the regular use of non-steroidal anti-inflammatory can reduce the risk of prostate cancer.
The study is reported in the current issue of the journal Cancer.
